Deerfield Management Company as of March 31, 2013
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 90 positions in its portfolio as reported in the March 2013 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Forest Laboratories | 4.8 | $80M | 2.1M | 38.04 | |
Teva Pharmaceutical Industries (TEVA) | 4.6 | $76M | 1.9M | 39.68 | |
Exelixis Inc cnv | 4.2 | $71M | 71M | 1.00 | |
Auxilium Pharmaceuticals | 4.2 | $69M | 4.0M | 17.29 | |
Array BioPharma | 3.3 | $55M | 11M | 4.91 | |
NxStage Medical | 3.3 | $55M | 4.9M | 11.28 | |
Keryx Biopharmaceuticals | 3.2 | $54M | 7.7M | 7.05 | |
Merck & Co (MRK) | 3.2 | $54M | 1.2M | 44.20 | |
Hologic Inc cnv | 3.0 | $50M | 48M | 1.05 | |
Nuvasive Inc. conv | 2.8 | $47M | 48M | 0.98 | |
Arena Pharmaceuticals | 2.6 | $44M | 5.3M | 8.21 | |
Brookdale Senior Living note | 2.5 | $42M | 35M | 1.21 | |
Sagent Pharmaceuticals | 2.2 | $37M | 2.1M | 17.55 | |
Dendreon Corp note | 2.2 | $37M | 46M | 0.80 | |
HeartWare International | 2.2 | $36M | 412k | 88.41 | |
Intermune Inc note 2.500% 9/1 | 2.1 | $35M | 42M | 0.84 | |
Pfizer (PFE) | 2.0 | $34M | 1.2M | 28.86 | |
Antares Pharma | 2.0 | $34M | 9.4M | 3.58 | |
Warner Chilcott Plc - | 2.0 | $33M | 2.5M | 13.55 | |
Alnylam Pharmaceuticals (ALNY) | 1.8 | $30M | 1.2M | 24.37 | |
Community Health Systems (CYH) | 1.8 | $29M | 620k | 47.39 | |
Molina Healthcare (MOH) | 1.8 | $29M | 953k | 30.87 | |
Nektar Therapeutics (NKTR) | 1.7 | $28M | 2.6M | 11.00 | |
Pharmacyclics | 1.7 | $28M | 345k | 80.41 | |
AngioDynamics (ANGO) | 1.6 | $27M | 2.4M | 11.43 | |
Bristol Myers Squibb (BMY) | 1.6 | $27M | 650k | 41.19 | |
Integra Lifesciences Holdings conv bnd | 1.6 | $26M | 25M | 1.02 | |
Charles Riv Labs Intl Inc note 2.250% 6/1 | 1.5 | $25M | 25M | 1.01 | |
Universal American | 1.3 | $22M | 2.6M | 8.33 | |
XenoPort | 1.3 | $22M | 3.0M | 7.15 | |
Cardinal Health (CAH) | 1.2 | $20M | 490k | 41.62 | |
St. Jude Medical | 1.2 | $20M | 500k | 40.44 | |
Gilead Sciences (GILD) | 1.2 | $20M | 400k | 48.94 | |
Accuray Inc Del note 3.750% 8/0 | 1.1 | $19M | 21M | 0.90 | |
Flamel Technologies | 1.1 | $19M | 4.3M | 4.30 | |
Achillion Pharmaceuticals | 1.1 | $19M | 2.1M | 8.75 | |
Optimer Pharmaceuticals | 1.1 | $18M | 1.5M | 11.90 | |
Express Scripts Holding | 1.0 | $17M | 290k | 57.62 | |
Cytokinetics | 0.9 | $15M | 13M | 1.14 | |
Allscripts Healthcare Solutions (MDRX) | 0.9 | $14M | 1.1M | 13.59 | |
Dendreon Corporation | 0.8 | $14M | 3.0M | 4.74 | |
Catamaran | 0.8 | $13M | 250k | 53.03 | |
Rigel Pharmaceuticals | 0.8 | $13M | 1.9M | 6.80 | |
Pacific Biosciences of California (PACB) | 0.7 | $12M | 4.9M | 2.49 | |
Dendreon Corp cnv | 0.7 | $12M | 13M | 0.93 | |
Amarin Corporation (AMRN) | 0.7 | $12M | 1.6M | 7.41 | |
Hca Holdings (HCA) | 0.7 | $12M | 284k | 40.63 | |
Tesaro | 0.6 | $9.9M | 452k | 21.96 | |
Cempra | 0.6 | $9.2M | 1.4M | 6.75 | |
Cross Country Healthcare (CCRN) | 0.5 | $9.0M | 1.7M | 5.31 | |
Anthera Pharmaceuticals | 0.5 | $8.9M | 14M | 0.66 | |
BioDelivery Sciences International | 0.5 | $8.1M | 1.9M | 4.21 | |
Itmn 2 1/2 12/15/17 | 0.5 | $7.8M | 7.5M | 1.04 | |
Sarepta Therapeutics (SRPT) | 0.4 | $7.4M | 200k | 36.95 | |
Liposcience | 0.4 | $6.6M | 624k | 10.51 | |
Progenics Pharmaceuticals | 0.3 | $5.6M | 1.0M | 5.38 | |
Alere Inc note 3.000% 5/1 | 0.3 | $5.6M | 5.8M | 0.98 | |
Ariad Pharmaceuticals | 0.3 | $5.5M | 302k | 18.08 | |
Accuray Inc note 3.500% 2/0 | 0.3 | $5.4M | 5.0M | 1.07 | |
BioScrip | 0.3 | $5.1M | 400k | 12.71 | |
AtriCure (ATRC) | 0.3 | $5.0M | 630k | 7.92 | |
Durata Therapeutics | 0.3 | $4.8M | 536k | 9.00 | |
Healthways | 0.3 | $4.4M | 357k | 12.25 | |
Celldex Therapeutics | 0.2 | $4.0M | 346k | 11.58 | |
Auxilium Pharmaceuticals note | 0.2 | $4.0M | 4.0M | 1.01 | |
eHealth (EHTH) | 0.2 | $3.5M | 197k | 17.88 | |
Accuray Incorporated (ARAY) | 0.2 | $3.3M | 720k | 4.64 | |
Alphatec Holdings | 0.2 | $3.1M | 1.4M | 2.11 | |
Clovis Oncology | 0.2 | $3.0M | 105k | 28.67 | |
Illumina (ILMN) | 0.2 | $2.8M | 52k | 53.98 | |
LCA-Vision | 0.2 | $2.9M | 856k | 3.36 | |
Vanguard Health Systems | 0.2 | $2.9M | 196k | 14.87 | |
Mannkind Corp note 3.750%12/1 | 0.2 | $2.8M | 3.1M | 0.89 | |
LifePoint Hospitals | 0.2 | $2.6M | 54k | 48.47 | |
Cerus Corporation (CERS) | 0.1 | $2.2M | 505k | 4.42 | |
USD.01 Mannkind Corp sr unsecured | 0.1 | $2.1M | 2.5M | 0.84 | |
Merge Healthcare | 0.1 | $2.0M | 689k | 2.89 | |
Cardiovascular Systems | 0.1 | $2.0M | 100k | 20.48 | |
Zogenix | 0.1 | $1.8M | 1.0M | 1.80 | |
Pernix Therapeutics Holdings | 0.1 | $1.9M | 383k | 4.96 | |
DepoMed | 0.1 | $1.5M | 250k | 5.87 | |
Masimo Corporation (MASI) | 0.1 | $1.4M | 70k | 19.61 | |
AVEO Pharmaceuticals | 0.1 | $1.2M | 161k | 7.35 | |
Palatin Technologies | 0.1 | $1.2M | 2.0M | 0.60 | |
Elan Corporation | 0.0 | $667k | 57k | 11.80 | |
Solta Medical | 0.0 | $746k | 339k | 2.20 | |
SIGA Technologies (SIGA) | 0.0 | $346k | 97k | 3.58 | |
Orexigen Therapeutics | 0.0 | $141k | 23k | 6.25 | |
Spectrum Pharmaceuticals | 0.0 | $237k | 32k | 7.46 | |
Icad (ICAD) | 0.0 | $194k | 39k | 4.99 |